98 related articles for article (PubMed ID: 29490686)
1. Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology.
Burgio G
Genome Biol; 2018 Feb; 19(1):27. PubMed ID: 29490686
[TBL] [Abstract][Full Text] [Related]
2. CRISPR: Beyond the Excitement.
Moustafa K
J Bioeth Inq; 2024 Mar; 21(1):7-9. PubMed ID: 38261130
[No Abstract] [Full Text] [Related]
3. Emerging Strategies for Genome Editing in the Brain.
Foss DV; Wilson RC
Trends Mol Med; 2018 Oct; 24(10):822-824. PubMed ID: 30104136
[TBL] [Abstract][Full Text] [Related]
4. Mouse Models for Drug Discovery. Can New Tools and Technology Improve Translational Power?
Zuberi A; Lutz C
ILAR J; 2016 Dec; 57(2):178-185. PubMed ID: 28053071
[TBL] [Abstract][Full Text] [Related]
5. Successful correction of hemophilia by CRISPR/Cas9 genome editing in vivo: delivery vector and immune responses are the key to success.
Nguyen TH; Anegon I
EMBO Mol Med; 2016 May; 8(5):439-41. PubMed ID: 27138565
[TBL] [Abstract][Full Text] [Related]
6. Mouse Genome Editing Using the CRISPR/Cas System.
Harms DW; Quadros RM; Seruggia D; Ohtsuka M; Takahashi G; Montoliu L; Gurumurthy CB
Curr Protoc Hum Genet; 2014 Oct; 83():15.7.1-27. PubMed ID: 25271839
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Mammalian In Vivo Enhancers Using Mouse Transgenesis and CRISPR Genome Editing.
Osterwalder M; Tran S; Hunter RD; Meky EM; von Maydell K; Harrington AN; Godoy J; Novak CS; Plajzer-Frick I; Zhu Y; Akiyama JA; Afzal V; Kvon EZ; Pennacchio LA; Dickel DE; Visel A
Methods Mol Biol; 2022; 2403():147-186. PubMed ID: 34913122
[TBL] [Abstract][Full Text] [Related]
8. Rapid in vivo multiplexed editing (RIME) of the adult mouse liver.
Katsuda T; Cure H; Sussman J; Simeonov KP; Krapp C; Arany Z; Grompe M; Stanger BZ
Hepatology; 2023 Aug; 78(2):486-502. PubMed ID: 36037289
[TBL] [Abstract][Full Text] [Related]
9. Multiple and Consecutive Genome Editing Using i-GONAD and Breeding Enrichment Facilitates the Production of Genetically Modified Mice.
Melo-Silva CR; Knudson CJ; Tang L; Kafle S; Springer LE; Choi J; Snyder CM; Wang Y; Kim SV; Sigal LJ
Cells; 2023 May; 12(9):. PubMed ID: 37174743
[TBL] [Abstract][Full Text] [Related]
10. Novel methods for the generation of genetically engineered animal models.
Cassidy A; Onal M; Pelletier S
Bone; 2023 Feb; 167():116612. PubMed ID: 36379415
[TBL] [Abstract][Full Text] [Related]
11. Improving Transgenesis Efficiency and CRISPR-Associated Tools Through Codon Optimization and Native Intron Addition in
Han Z; Lo WS; Lightfoot JW; Witte H; Sun S; Sommer RJ
Genetics; 2020 Dec; 216(4):947-956. PubMed ID: 33060138
[TBL] [Abstract][Full Text] [Related]
12. CRISPR base editing-mediated correction of a tau mutation rescues cognitive decline in a mouse model of tauopathy.
Gee MS; Kwon E; Song MH; Jeon SH; Kim N; Lee JK; Koo T
Transl Neurodegener; 2024 Apr; 13(1):21. PubMed ID: 38610033
[No Abstract] [Full Text] [Related]
13. Accelerating functional gene discovery in osteoarthritis.
Butterfield NC; Curry KF; Steinberg J; Dewhurst H; Komla-Ebri D; Mannan NS; Adoum AT; Leitch VD; Logan JG; Waung JA; Ghirardello E; Southam L; Youlten SE; Wilkinson JM; McAninch EA; Vancollie VE; Kussy F; White JK; Lelliott CJ; Adams DJ; Jacques R; Bianco AC; Boyde A; Zeggini E; Croucher PI; Williams GR; Bassett JHD
Nat Commun; 2021 Jan; 12(1):467. PubMed ID: 33473114
[TBL] [Abstract][Full Text] [Related]
14. Genome editing of 3' UTR-embedded inhibitory region enables generation of gene knock-up alleles in plants.
Wang H; Zhang D; Chen M; Meng X; Bai S; Xin P; Yan J; Chu J; Li J; Yu H
Plant Commun; 2024 Mar; 5(3):100745. PubMed ID: 37946411
[No Abstract] [Full Text] [Related]
15. Approaches for timeline reductions in pathogenesis studies using genetically modified mice.
Skavicus S; Heaton NS
Microbiol Spectr; 2023 Sep; 11(5):e0252123. PubMed ID: 37695101
[TBL] [Abstract][Full Text] [Related]
16. Programming schistosomes - a crisper approach to transgenesis.
Kalinna BH
Trends Parasitol; 2023 Nov; 39(11):896-897. PubMed ID: 37718190
[TBL] [Abstract][Full Text] [Related]
17. The Cancer Dependency Map enables drug mechanism-of-action investigations.
Vazquez F; Boehm JS
Mol Syst Biol; 2020 Jul; 16(7):e9757. PubMed ID: 32696566
[TBL] [Abstract][Full Text] [Related]
18. Removal of evolutionarily conserved functional MYC domains in a tilapia cell line using a vector-based CRISPR/Cas9 system.
Kim C; Cnaani A; Kültz D
Sci Rep; 2023 Jul; 13(1):12086. PubMed ID: 37495710
[TBL] [Abstract][Full Text] [Related]
19. A CRISPR/Cas12a-assisted rapid detection platform by biosensing the
Luan T; Wang L; Zhao J; Luan H; Zhang Y; Wang C; Langford PR; Liu S; Zhang W; Li G
Front Microbiol; 2022; 13():928307. PubMed ID: 36160205
[No Abstract] [Full Text] [Related]
20. Using CRISPR to understand and manipulate gene regulation.
Akinci E; Hamilton MC; Khowpinitchai B; Sherwood RI
Development; 2021 May; 148(9):. PubMed ID: 33913466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
